<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/hitk" ></link>
<id>urn:uuid:2b7a25bd-7a11-43e3-2a29-6169c968a293</id>
<updated>2013-06-18T20:13:06-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>HITK: SELTZER REUBEN (VCB,DIR) Acquired (JB) 350 Shares of HI TECH PHARMACAL CO INC for $0.00 on 12/25</title>
<link href="http://www.insiderinsights.com/company/hitk/hi-tech-pharmacal-co-inc/id-2450586" ></link>
<id>urn:uuid:aca54159-dfb4-d180-6895-8c0ac719cd1f</id>
<updated>2013-06-13T09:39:51-04:00</updated>
<summary type="html" ><![CDATA[HI TECH PHARMACAL CO INC (HITK). Recent Price: $33.20. Mkt Cap:450.6mm. 10D Vol: 160k]]></summary>
</entry>
<entry>
<title>HITK: SELTZER REUBEN (VCB,DIR) Acquired (JB) 2,450 Shares of HI TECH PHARMACAL CO INC for $0.00 on 12/25</title>
<link href="http://www.insiderinsights.com/company/hitk/hi-tech-pharmacal-co-inc/id-2450587" ></link>
<id>urn:uuid:80cbea37-6fc8-0860-30a2-68ee8fffe61e</id>
<updated>2013-06-13T09:39:51-04:00</updated>
<summary type="html" ><![CDATA[HI TECH PHARMACAL CO INC (HITK). Recent Price: $33.20. Mkt Cap:450.6mm. 10D Vol: 160k]]></summary>
</entry>
<entry>
<title>HITK: DURRANT CAMERON (PR,CEO) Filed a Form 3, Becoming a Registered Insider at HI TECH PHARMACAL CO INC With Initial Direct Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/hitk/hi-tech-pharmacal-co-inc/id-2387420" ></link>
<id>urn:uuid:2113730f-3864-187c-2336-8411dab5e8e3</id>
<updated>2013-03-13T11:59:14-04:00</updated>
<summary type="html" ><![CDATA[HI TECH PHARMACAL CO INC (HITK). Recent Price: $33.20. Mkt Cap:450.6mm. 10D Vol: 160k]]></summary>
</entry>
<entry>
<title>HITK: PETERS WILLIAM J (VP,CFO) Exercised 4,639 Options (OE) of HI TECH PHARMACAL CO INC for $10.68 on 2/1-2/5, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/hitk/hi-tech-pharmacal-co-inc/id-2346811" ></link>
<id>urn:uuid:00679180-0ca5-6fb6-2ba1-a826521de6db</id>
<updated>2013-02-05T17:32:49-05:00</updated>
<summary type="html" ><![CDATA[HI TECH PHARMACAL CO INC (HITK). Recent Price: $33.20. Mkt Cap:450.6mm. 10D Vol: 160k]]></summary>
</entry>
<entry>
<title>HITK: PETERS WILLIAM J (VP,CFO) Exercised 7,861 Options (OE) of HI TECH PHARMACAL CO INC for $10.68 on 1/24, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/hitk/hi-tech-pharmacal-co-inc/id-2339227" ></link>
<id>urn:uuid:fca9de81-82ed-304b-2e84-9f63bf7a3dac</id>
<updated>2013-01-28T17:31:39-05:00</updated>
<summary type="html" ><![CDATA[HI TECH PHARMACAL CO INC (HITK). Recent Price: $33.20. Mkt Cap:450.6mm. 10D Vol: 160k]]></summary>
</entry>
<entry>
<title>HITK: SELTZER DAVID S (CEO,PR,SEC,TR,DIR,BO) Acquired (JB) 350 Shares of HI TECH PHARMACAL CO INC for $0.00 on 12/26</title>
<link href="http://www.insiderinsights.com/company/hitk/hi-tech-pharmacal-co-inc/id-2331341" ></link>
<id>urn:uuid:26f0c76c-1c3f-3fa5-8691-71cadbc4ed90</id>
<updated>2013-01-11T15:09:16-05:00</updated>
<summary type="html" ><![CDATA[HI TECH PHARMACAL CO INC (HITK). Recent Price: $33.20. Mkt Cap:450.6mm. 10D Vol: 160k]]></summary>
</entry>
<entry>
<title>HITK: SELTZER DAVID S (CEO,PR,SEC,TR,DIR,BO) Acquired (JB) 1,050 Shares of HI TECH PHARMACAL CO INC for $0.00 on 12/26</title>
<link href="http://www.insiderinsights.com/company/hitk/hi-tech-pharmacal-co-inc/id-2331342" ></link>
<id>urn:uuid:3395435f-43cc-fef5-2afe-e62d8108500a</id>
<updated>2013-01-11T15:09:16-05:00</updated>
<summary type="html" ><![CDATA[HI TECH PHARMACAL CO INC (HITK). Recent Price: $33.20. Mkt Cap:450.6mm. 10D Vol: 160k]]></summary>
</entry>
</feed>